Back
Apellis Pharmaceuticals Vs. Repligen Industry Stock Comparison
Sell
30
APLS
Apellis Pharmaceuticals
Last Price:
26.19
Seasonality Move:
20.78%
Sell
30
RGEN
Repligen
Last Price:
123.45
Seasonality Move:
7.3%
Sell
30
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $26.18. The Score for APLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $123.41. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $26.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
RGEN Stock Price Chart
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 35.91 | Sell |
| Chaikin Money Flow: | -364136 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.93 - 28.79) | Sell |
| Bollinger Bands (100): | (28.92 - 38.96) | Sell |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 35.41 | Sell |
| Chaikin Money Flow: | -341870 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.29 | Sell |
| 20-day SMA: | 27.92 | Sell |
| 50-day SMA: | 29.89 | Sell |
| 200-day SMA: | 43.11 | Sell |
| 8-day EMA: | 27.67 | Sell |
| 20-day EMA: | 28.11 | Sell |
| 50-day EMA: | 30.08 | Sell |
| 200-day EMA: | 39.9 | Sell |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
Apellis Pharmaceuticals Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||